Ricerca

Pubblicazioni IRIS

• Partial Inhibition Of Nampt Restores Metabolic Vulnerability And Synergizes With Anti-Myeloma Agents In Multiple Myeloma
  Anno: 2026
• Severe hypereosinophilia and eosinophilic myocarditis during secondary plasma cell leukemia: evidence of a paraneoplastic manifestation of aggressive myeloma evolution.
  Anno: 2026
• Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1
  Anno: 2025
• Monoclonal gammopathy of renal significance (MGRS): retrospective monocentric analysis of clinical outcomes and treatment strategies
  Anno: 2025
• CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma
  Anno: 2025